Skip to content

A Pilot Feasibility Study of Mindfulness-Oriented Recovery Enhancement With Pregnant Women With Opioid Use Disorder

The Mindful Pregnancy Study: A Pilot Feasibility Study of Mindfulness-Oriented Recovery Enhancement With Pregnant Women With Opioid Use Disorder

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04824521
Enrollment
1
Registered
2021-04-01
Start date
2021-10-01
Completion date
2023-08-01
Last updated
2024-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid-use Disorder

Brief summary

Thirty pregnant women with substance use disorder will be recruited to participate in eight sessions of MORE.

Detailed description

Participants will be asked to complete a battery of self-report measures and a semi-structured qualitative interview at three times points-before the intervention begins, after session four, and again after session eight. Participants will also be asked to complete self-report measures before and after each session. The primary aims of this study are as follows. Aim 1: To adapt the in-person MORE intervention for telehealth delivery. Aim 2: To assess the overall feasibility and acceptability of this telehealth intervention. Hypothesis: MORE delivered via telehealth will be both feasible and acceptable to participants.

Interventions

MORE is a mindfulness-based intervention.

Sponsors

National Institute of General Medical Sciences (NIGMS)
CollaboratorNIH
University of Montana
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Must be pregnant. * Must be able to communicate in English. * Must have met criteria for opioid use disorder in the past year.

Exclusion criteria

* None.

Design outcomes

Primary

MeasureTime frameDescription
Client Satisfaction8 weeksParticipants will complete the Client Satisfaction Questionnaire.

Secondary

MeasureTime frameDescription
SUD Symptoms - Mini Neuropsychiatric Interview8 weeksThe Mini Neuropsychiatric Interview is a brief structured diagnostic interview for the major psychiatric disorders in the DSM-V. For this study, we conducted a structured interview with participants to determine the number of symptoms of substance use disorder they had experienced in the past year. After completing eight sessions of Mindfulness-Oriented Recovery Enhancement, we conducted the same interview to learn the number of symptoms of substance use disorder participants had experienced in the past eight weeks.

Countries

United States

Participant flow

Recruitment details

Study recruitment began 2/10/21 upon IRB approval and ended on 5/1/22. Recruitment efforts included outreach to OBGYN providers, healthcare systems, pain management clinics, substance use treatment providers, community groups, and harm reduction services. Providers and community members were asked to refer potential participants to the study and to post flyers. The team also advertised online through social media.

Pre-assignment details

We did not exclude any participants from the study before assignment to groups.

Participants by arm

ArmCount
Mindfulness-Oriented Recovery Enhancement Via Tele-health
Participants will be assigned to 8 weeks of Mindfulness-Oriented Recovery Enhancement delivered via tele-health. Mindfulness-Oriented Recovery Enhancement: MORE is a mindfulness-based intervention.
1
Total1

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up1

Baseline characteristics

CharacteristicMindfulness-Oriented Recovery Enhancement Via Tele-health
Age, Continuous31 years
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
0 Participants
Region of Enrollment
United States
1 participants
Sex: Female, Male
Female
1 Participants
Sex: Female, Male
Male
0 Participants
SUD Symptoms - Mini Neuropsychiatric Interview - Alcohol Use Disorder12 symptoms

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 1
other
Total, other adverse events
0 / 1
serious
Total, serious adverse events
0 / 1

Outcome results

Primary

Client Satisfaction

Participants will complete the Client Satisfaction Questionnaire.

Time frame: 8 weeks

Population: Participant did not complete this measure.

Secondary

SUD Symptoms - Mini Neuropsychiatric Interview

The Mini Neuropsychiatric Interview is a brief structured diagnostic interview for the major psychiatric disorders in the DSM-V. For this study, we conducted a structured interview with participants to determine the number of symptoms of substance use disorder they had experienced in the past year. After completing eight sessions of Mindfulness-Oriented Recovery Enhancement, we conducted the same interview to learn the number of symptoms of substance use disorder participants had experienced in the past eight weeks.

Time frame: 8 weeks

ArmMeasureValue (NUMBER)
Mindfulness-Oriented Recovery Enhancement Via Tele-healthSUD Symptoms - Mini Neuropsychiatric Interview12 symptoms

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026